<PAGE>
FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
August 14, 1996
ROBERTS PHARMACEUTICAL CORPORATION
- --------------------------------------------------------------------------------
(exact name of registrant as specified in its charter)
NEW JERSEY 1-1-432 22-2429994
- ----------------- ------------------ ----------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
Meridian Center II
4 Industrial Way West
Eatontown, New Jersey 07724
- --------------------------------------------------------------------------------
(Address of principal executive offices, including zip code)
Registrant's telephone number, including area code: 908-389-1182
Meridian Center II
4 Industrial Way West
Eatontown, New Jersey 07724
- --------------------------------------------------------------------------------
(Former name or former address, if changed from last report)
<PAGE>
-2-
Item 5. Other Events
------------
Roberts Pharmaceutical Corporation announced that it has
entered into a Letter of Intent with Monarch Pharmaceuticals, Inc. concerning
Roberts' intentions to sell the COMHIST(R), NUCOFED(R) and QUIBRON(R) lines of
pharmaceutical products.
Roberts intends to sell to Monarch which intends to purchase, all the
U.S. rights, titles and interests in the COMHIST(R), NUCOFED(R) AND QUIBRON(R)
product lines, including all intellectual properties, regulatory dossiers and
approvals, formulations, trademarks, sales contracts and the like. The parties
intend to commence negotiations leading to a definitive asset purchase agreement
as soon as possible.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ROBERTS PHARMACEUTICAL CORPORATION
----------------------------------
(Registrant)
Date: August 20, 1996 By: /s/ Anthony A. Rascio
------------------------------
Anthony A. Rascio
Vice President
